Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02681224 · ClinicalTrials.gov registry record · NA
TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest
A NA study, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT02681224 is a NA study that has completed, run by Goldman, Butterwick, Fitzpatrick and Groff. The registered enrollment target is 17 participants.
The verdict
NCT02681224, a NA study, has completed, sponsored by Goldman, Butterwick, Fitzpatrick and Groff.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
A single site, double-blind, randomized, placebo-controlled, clinical study comparing the difference between a novel healing gel and a placebo gel on post laser-resurfacing chests.
Interventions
- OTHER TR987 Gel with Silon Bandage
- OTHER TR987 without Silon Bandage
- OTHER Placebo Gel with Silon Bandage
- OTHER Placebo Gel without Silon Bandage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2015-09 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02681224
The ClinicalTrials.gov registry entry for NCT02681224 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which TR987 Gel with Silon Bandage is the first listed.
NCT02681224 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02681224 about?
NCT02681224 is a clinical study titled "TR-987 vs. Placebo Following Fractionated CO2 Laser Resurfacing of the Chest". A single site, double-blind, randomized, placebo-controlled, clinical study comparing the difference between a novel healing gel and a placebo gel on post laser-resurfacing chests.
What is the current status of trial NCT02681224?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2015-09. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02681224?
The interventions under investigation include: TR987 Gel with Silon Bandage (OTHER), TR987 without Silon Bandage (OTHER), Placebo Gel with Silon Bandage (OTHER), Placebo Gel without Silon Bandage (OTHER).
Who is sponsoring clinical trial NCT02681224?
This trial is sponsored by Goldman, Butterwick, Fitzpatrick and Groff, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.